当前位置:首页 > 文献互助 > 互助详情

CLO26-102: Progression-Free Survival of Pembrolizumab Monotherapy Versus Combination Therapy With Chemotherapy as First-Line Treatment in Advanced or Metastatic Non-Small-Cell Lung Cancer Without EGFR/ALK Mutations复制

用户EO9nReo4Hj6s 1个月前 81 10 已关闭

DOI: 10.6004/jnccn.2025.7194复制

文献链接: https://jnccn.org/view/journals/jnccn/24/3.5/article-CLO26-102.xml复制

其他信息:

出版社: Harborside Press, LLC
作者: Woojung Yang; Youjin Oh

互助时间线

2026-04-27 15:09:18 [关闭求助]

系统关闭了求助

2026-04-22 15:09:18 [发起求助]